Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B S Kramer

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Journal of the National Cancer Institute|November 20, 1991
Analysis of the role of cancer prevention and control measures in reducing cancer mortalityK C Chu, B S Kramer, C R Smart
Hematology/Oncology Clinics of North America|January 15, 1999
Phase III, large-scale chemoprevention trials. Approach to chemoprevention clinical trials and phase III clinical trial of tamoxifen as a chemopreventive for breast cancer--the US National Cancer Institute experienceB K Dunn, B S Kramer, L G Ford
BMC Medical Research Methodology|October 17, 2001
The paired availability design for historical controlsS G Baker, K S Lindeman, B S Kramer
Southern Medical Journal|April 1, 1986
Thrombotic thrombocytopenic purpura associated with metastatic gastric adenocarcinoma: successful management with plasmapheresisD J Carr, B S Kramer, D E Dragonetti
Drug Intelligence & Clinical Pharmacy|June 1, 1985
Effect of filtering amphotericin B infusions on the incidence and severity of phlebitis and selected adverse reactionsV P Gotz, K H Rand, B S Kramer
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Is screening for prostate cancer the current gold standard?--"no"B S Kramer, J K Gohagan, P C Prorok
American Journal of Veterinary Research|August 1, 1982
Efficacy of injectable and oral paste formulations of ivermectin against gastrointestinal parasites in poniesB J Torbert, B S Kramer, T R Klei
Cancer Treatment Reports|March 1, 1985
Phase II evaluation of amsacrine in small cell lung cancer: a Southeastern Cancer Study Group trialB S Kramer, R Birch, L Einhorn, et al.
Immunology Series|January 1, 1990
Biological, molecular, and clinical markers for the diagnosis and typing of lung cancerA F Gazdar, J L Mulshine, B S Kramer
Biochemistry|December 16, 1975
Reaction of 1,3-bis(2-chloroethyl)-1-nitrosourea with synthetic polynucleotidesD B Ludlum, B S Kramer, J Wang, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Journal of the National Cancer Institute|November 20, 1991
Analysis of the role of cancer prevention and control measures in reducing cancer mortalityK C Chu, B S Kramer, C R Smart
Hematology/Oncology Clinics of North America|January 15, 1999
Phase III, large-scale chemoprevention trials. Approach to chemoprevention clinical trials and phase III clinical trial of tamoxifen as a chemopreventive for breast cancer--the US National Cancer Institute experienceB K Dunn, B S Kramer, L G Ford
BMC Medical Research Methodology|October 17, 2001
The paired availability design for historical controlsS G Baker, K S Lindeman, B S Kramer
Southern Medical Journal|April 1, 1986
Thrombotic thrombocytopenic purpura associated with metastatic gastric adenocarcinoma: successful management with plasmapheresisD J Carr, B S Kramer, D E Dragonetti
Drug Intelligence & Clinical Pharmacy|June 1, 1985
Effect of filtering amphotericin B infusions on the incidence and severity of phlebitis and selected adverse reactionsV P Gotz, K H Rand, B S Kramer
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Is screening for prostate cancer the current gold standard?--"no"B S Kramer, J K Gohagan, P C Prorok
American Journal of Veterinary Research|August 1, 1982
Efficacy of injectable and oral paste formulations of ivermectin against gastrointestinal parasites in poniesB J Torbert, B S Kramer, T R Klei
Cancer Treatment Reports|March 1, 1985
Phase II evaluation of amsacrine in small cell lung cancer: a Southeastern Cancer Study Group trialB S Kramer, R Birch, L Einhorn, et al.
Immunology Series|January 1, 1990
Biological, molecular, and clinical markers for the diagnosis and typing of lung cancerA F Gazdar, J L Mulshine, B S Kramer
Biochemistry|December 16, 1975
Reaction of 1,3-bis(2-chloroethyl)-1-nitrosourea with synthetic polynucleotidesD B Ludlum, B S Kramer, J Wang, et al.
Pageof 9